Basit öğe kaydını göster

dc.contributor.authorÖZEN, SEZA
dc.contributor.authorAyaz, Nuray
dc.contributor.authorSozeri, Betul
dc.contributor.authorDemirkaya, Erkan
dc.contributor.authorBarut, Kenan
dc.contributor.authorKasapcopur, Ozgur
dc.contributor.authorRuperto, Nicolino
dc.contributor.authorBovis, Francesca
dc.contributor.authorConsolaro, Alessandro
dc.contributor.authorCakan, Mustafa
dc.contributor.authorSimsek, Dogan
dc.contributor.authorFidanci, Berna Eren
dc.contributor.authorMAKAY, BALAHAN
dc.contributor.authorUnsal, Erbil
dc.date.accessioned2021-03-03T12:48:30Z
dc.date.available2021-03-03T12:48:30Z
dc.identifier.citationDemirkaya E., ÖZEN S., Sozeri B., Ayaz N., Kasapcopur O., Unsal E., MAKAY B., Barut K., Fidanci B. E. , Simsek D., et al., "The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)", RHEUMATOLOGY INTERNATIONAL, cilt.38, ss.395-402, 2018
dc.identifier.issn0172-8172
dc.identifier.otherav_3034b9a8-db6c-4452-adc9-0c56a5e5ef75
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/36897
dc.identifier.urihttps://doi.org/10.1007/s00296-018-3982-8
dc.description.abstractThe Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Turkish language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the 3 Likert assumptions, floor/ceiling effects, internal consistency, Cronbach's alpha, interscale correlations, test-retest reliability, and construct validity (convergent and discriminant validity). A total of 466 JIA patients (13.7% systemic, 40.6% oligoarticular, 22.5% RF negative poly-arthritis, and 23.2% other categories) and 93 healthy children were enrolled in four centres. The JAMAR components discriminated well-healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Turkish version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectİmmünoloji ve Romatoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectROMATOLOJİ
dc.titleThe Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
dc.typeMakale
dc.relation.journalRHEUMATOLOGY INTERNATIONAL
dc.contributor.departmentAntalya Life Hosp , ,
dc.identifier.volume38
dc.identifier.startpage395
dc.identifier.endpage402
dc.contributor.firstauthorID252679


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster